Endoscopic ablative therapy for Barrett's esophagus: Current status

Gastrointestinal Endoscopy

Volumn 59, Issue 1, 2004, Pages 66-69

  Sampliner, Richard E ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; OMEPRAZOLE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PROTON PUMP INHIBITOR;

BARRETT ESOPHAGUS; CANCER PREVENTION; CLINICAL TRIAL; DYSPLASIA; EARLY DIAGNOSIS; EDITORIAL; ELECTROCOAGULATION; ENDOSCOPIC ABLATIVE THERAPY; ENDOSCOPIC THERAPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; HISTOPATHOLOGY; HUMAN; HYPERTHERMIC THERAPY; INTERMETHOD COMPARISON; NEODYMIUM LASER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SAFETY; SURVIVAL RATE; TREATMENT INDICATION;

BARRETT ESOPHAGUS; COMBINED MODALITY THERAPY; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGUS; HUMANS; LASER COAGULATION; METAPLASIA; PHOTOCHEMOTHERAPY;

EID: 0347003756     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(03)02380-0     Document Type: Editorial

References (24)

1. Ackroyd R, Tam W, Schoeman M, Devitt PG, Watson DI. Prospective randomized controlled trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus in patients following anti-reflux surgery. Gastrointest Endosc 2004;59:1-7.
2. Kahaleh M, VanLaethem JL, Nagy N, Cremer M, Deviere J. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 2002;34:950-5.
3. Schulz H, Miehlke S, Antos D, Schentke KU, Vieth M, Stolte M, Bayerdorffer E. Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc 2000;51:659-63.
4. Byrne JP, Armstrong GR, Attwood SEA. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol 1998;93:1810-5.
5. Pereiera-Lima J, Busnello JV, Saul C, Toneloto EB, Lopes CV, Rynkowski CB, et al. High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am J Gastroenterol 2000;95:1661-8.
6. Gossner L, Stolte M, Sroka R, Rick K, May A, Hahg EG, et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998;114:448-55.
7. Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early carcinoma: long-term results. Gastrointest Endosc 2003;58:183-8.
8. Overholt B, Lightdale C, Wang K, Canto M, Burdick S, Barr H, et al. International, multicenter, partially blinded, randomised study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in Barrett's esophagus (BE): Results of 24-month follow-up [abstract]. Gastroenterology 2003;124:A20.
9. Ell C, May A, Gossner L, Pech O, Gunter E, Mayer G, et al. Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118:670-7.
10. May A, Gossner L, Pech O, Fritz A, Gunter E, Mayer G, et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Heptaol 2002;14:1085-91.
11. May A, Gossner L, Behrens A, Kohnen R, Vieth M, Stolte M, et al. A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc 2003;58:167-75.
12. Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastroenterology 2000;52:328-32.
13. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high grade dysplasia: an indication for prophylactic esophagectomy. Ann Surg 1996;224:66-71.
14. Overholt B, Panjehpour M, Tefftellar E, Rose M. Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus. Gastrointest Endosc 1993;39:73-6.
15. Buttar NS, Wang KK, Lutzke LS, Krishnadath KK, Anderson MA, et al. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia with Barrett's esophagus. Gastrointest Endosc 2001;54:682-8.
16. Ormsby AH, Petras RE, Henricks WH, Easley K, Rice TW, Rybicki LA, et al. Interobserver variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 2002;51:671-6.
17. VanDerBurgh A, Doos J, Hop WJC, VanBlankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996;39:5-8.
18. MacDonald CE, Wicks AC, Playford RJ. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. BMJ 2000;321:1252-5.
19. Anderson LA, Murray LJ, Murphy SJ, Fitzpatrick DA, Johnston BT, Watson RGP, et al. Mortality in Barrett's oesophagus: results from a population based study. Gut 2003;52:1081-4.
20. U.S. Food and Drug Administration. FDA approves photofrin for treatment of pre-cancerous lesions in Barrett's esophagus. FDA 2003.
21. Fennerty MB. Endoscopic ablation of Barrett's related neoplasia: what is the evidence supporting its use? Gastrointest Endosc 2003;58:246-7.
22. Scheiman JM, Wang KK. EMR for early stage esophageal cancer: setting the stage for improved patient outcomes. Gastrointest Endosc 2003;58:244-5.
23. Sampliner RE, Camargo L, Fass R. Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus. Am J Gastroenterol 2002;97:270-2.
24. Krishnadath KK, Wang KK, Taniguchi K, Sebo TJ, Buttar NS, Anderson MA, et al. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 2000;119:624-30.